BioNetwork West 2015 (past event)

October 26 - 28, 2015

Contact Us: 1.888.482.6012

Michael Attar


Executive Director, Business Development
Celgene Corporation

Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda

Innovative Dealmaking

Friday, February 10th, 2017


09:00 Therapeutic Focus Area Ice Breaker Roundtables

Get to know others with similar interests as you. Choose the therapeutic area at the top of your partnership priorities. You'll sit with 10 - 20 others seeking similar opportunities to debate the advantages and challenges assocatied with your chosen area, and start making connections!

#1 Neurodegenerative Diseases
Ilan Zipkin, Senior Investment Director, Takeda Ventures

#2 Rare Disease
Joshua A. Grass, SVP, Business and Corporate Development, BioMarin Pharmaceutical

#3 Biosimilars Across Therapeutic Areas
Michael Bayewitch, Director, Search & Evaluation, Biologics, Teva Pharmaceuticals

#4 Immunology
Kia Motesharei, Head, Global Licensing & Business Development, Immunology, EMD Serono

#5 Gene Therapy
John McDonald, VP Business Development and Mergers & Acquisitions, Biogen

#6 Oncology
Michael Attar, Executive Director, Business Development, Celgene Corporation

#7 Other (Free Flow Table)